Entropy founder Tux Pacific says the startup is winding up and will return capital to investors.
Entropy Founder Winds up Startup, Shifts Focus From Crypto to Pharma
WRITTEN BY
SHARE
Entropy founder and CEO Tux Pacific announces winding up the company effective after four years of operation, several pivots and two rounds of layoffs, and says the team worked through the latter half of 2025 on a crypto automations platform with threshold cryptography, trusted execution environments (TEEs) and artificial intelligence (AI) integrations. The post is addressed publicly by Pacific (Voltairine Novatore Pacific) and names support from A16z; remaining staff are being offered help finding new roles.
The wind‑up matters because Pacific is returning capital to investors and the core product was judged not to be venture scale, limiting further fundraising; Pacific notes a planned break and a shift toward pharmaceutical research on estradiol formulations and hormone delivery for women and transgender HRT, and invites pharma or medicine experts to contact them. Availability of team members for hire is being facilitated by Pacific, and any remaining actions are subject to investor and jurisdictional approvals.
Read More: A16z Researcher Explains Why Bitcoin and Ethereum Face Different Quantum Risks Than You’ve Been Told
🧭 FAQs
• Who is winding up Entropy? Tux Pacific (Voltairine Novatore Pacific), founder and CEO, announced the wind‑up.
• When did the team work on the crypto automations platform? The team worked on the platform during the latter half of 2025.
• Will investors get their capital back? Pacific states capital will be returned to investors, subject to final approvals.
• How can local candidates or pharma experts contact the founder? Pacific invites interested hires and pharma experts to reach out directly to Tux Pacific via their public channels.
